Annual FCF
-$3.16 M
-$1.33 M-72.82%
01 December 2023
Summary:
Lipella Pharmaceuticals Common Stock annual free cash flow is currently -$3.16 million, with the most recent change of -$1.33 million (-72.82%) on 01 December 2023. During the last 3 years, it has fallen by -$3.14 million (-10965.03%). LIPO annual FCF is now -10965.03% below its all-time high of -$28.60 thousand, reached on 01 December 2020.LIPO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$653.10 K
+$265.70 K+28.92%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock quarterly free cash flow is currently -$653.10 thousand, with the most recent change of +$265.70 thousand (+28.92%) on 01 September 2024. Over the past year, it has increased by +$74.60 thousand (+10.25%). LIPO quarterly FCF is now -676.58% below its all-time high of -$84.10 thousand, reached on 01 March 2021.LIPO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$3.69 M
+$50.70 K+1.36%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock TTM free cash flow is currently -$3.69 million, with the most recent change of +$50.70 thousand (+1.36%) on 01 September 2024. Over the past year, it has dropped by -$523.40 thousand (-16.54%). LIPO TTM FCF is now -4285.26% below its all-time high of -$84.10 thousand, reached on 01 March 2021.LIPO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIPO Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +10.3% | -16.5% |
| 3 y3 years | -10000.0% | -38.6% | -272.8% |
| 5 y5 years | - | - | - |
LIPO Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | <-9999.0% | at low | -182.0% | +53.0% | -272.8% | +1.4% |
| 5 y | 5 years | <-9999.0% | at low | -676.6% | +53.0% | -4285.3% | +1.4% |
| alltime | all time | <-9999.0% | at low | -676.6% | +53.0% | -4285.3% | +1.4% |
Lipella Pharmaceuticals Common Stock Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$653.10 K(-28.9%) | -$3.69 M(-1.4%) |
| June 2024 | - | -$918.80 K(-33.8%) | -$3.74 M(+7.6%) |
| Mar 2024 | - | -$1.39 M(+90.8%) | -$3.48 M(+9.8%) |
| Dec 2023 | -$3.16 M(+72.8%) | -$727.70 K(+3.4%) | -$3.16 M(+18.6%) |
| Sept 2023 | - | -$703.80 K(+7.4%) | -$2.67 M(+16.8%) |
| June 2023 | - | -$655.10 K(-39.2%) | -$2.28 M(+3.4%) |
| Mar 2023 | - | -$1.08 M(+365.5%) | -$2.21 M(+20.7%) |
| Dec 2022 | -$1.83 M | -$231.60 K(-27.7%) | -$1.83 M(-11.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$320.20 K(-44.8%) | -$2.07 M(+8.9%) |
| June 2022 | - | -$580.00 K(-17.1%) | -$1.90 M(+18.5%) |
| Mar 2022 | - | -$699.40 K(+48.4%) | -$1.60 M(+62.2%) |
| Dec 2021 | -$989.30 K(+3359.1%) | - | - |
| Dec 2021 | - | -$471.20 K(+212.3%) | -$989.30 K(+90.9%) |
| Sept 2021 | - | -$150.90 K(-46.7%) | -$518.10 K(+41.1%) |
| June 2021 | - | -$283.10 K(+236.6%) | -$367.20 K(+336.6%) |
| Mar 2021 | - | -$84.10 K | -$84.10 K |
| Dec 2020 | -$28.60 K | - | - |
FAQ
- What is Lipella Pharmaceuticals Common Stock annual free cash flow?
- What is the all time high annual FCF for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly free cash flow?
- What is the all time high quarterly FCF for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly FCF year-on-year change?
- What is Lipella Pharmaceuticals Common Stock TTM free cash flow?
- What is the all time high TTM FCF for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock TTM FCF year-on-year change?
What is Lipella Pharmaceuticals Common Stock annual free cash flow?
The current annual FCF of LIPO is -$3.16 M
What is the all time high annual FCF for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high annual free cash flow is -$28.60 K
What is Lipella Pharmaceuticals Common Stock quarterly free cash flow?
The current quarterly FCF of LIPO is -$653.10 K
What is the all time high quarterly FCF for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high quarterly free cash flow is -$84.10 K
What is Lipella Pharmaceuticals Common Stock quarterly FCF year-on-year change?
Over the past year, LIPO quarterly free cash flow has changed by +$74.60 K (+10.25%)
What is Lipella Pharmaceuticals Common Stock TTM free cash flow?
The current TTM FCF of LIPO is -$3.69 M
What is the all time high TTM FCF for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high TTM free cash flow is -$84.10 K
What is Lipella Pharmaceuticals Common Stock TTM FCF year-on-year change?
Over the past year, LIPO TTM free cash flow has changed by -$523.40 K (-16.54%)